Loponte Rosa, Pagnini Ugo, Iovane Giuseppe, Pisanelli Giuseppe
Department of Veterinary Medicine and Animal Production, University of Naples Federico II, via Federico Delpino, 1, 80137 Naples, Italy.
Antibiotics (Basel). 2021 Apr 11;10(4):421. doi: 10.3390/antibiotics10040421.
To overcome the obstacle of antimicrobial resistance, researchers are investigating the use of phage therapy as an alternative and/or supplementation to antibiotics to treat and prevent infections both in humans and in animals. In the first part of this review, we describe the unique biological characteristics of bacteriophages and the crucial aspects influencing the success of phage therapy. However, despite their efficacy and safety, there is still no specific legislation that regulates their use. In the second part of this review, we describe the comprehensive research done in the past and recent years to address the use of phage therapy for the treatment and prevention of bacterial disease affecting domestic animals as an alternative to antibiotic treatments. While in farm animals, phage therapy efficacy perspectives have been widely studied in vitro and in vivo, especially for zoonoses and diseases linked to economic losses (such as mastitis), in pets, studies are still few and rather recent.
为克服抗菌药物耐药性这一障碍,研究人员正在研究使用噬菌体疗法作为抗生素的替代方法和/或补充手段,以治疗和预防人类及动物的感染。在本综述的第一部分,我们描述了噬菌体独特的生物学特性以及影响噬菌体疗法成功的关键因素。然而,尽管噬菌体疗法有效且安全,但仍没有专门规范其使用的法规。在本综述的第二部分,我们描述了过去及近年来为解决将噬菌体疗法用于治疗和预防影响家畜的细菌性疾病以替代抗生素治疗所开展的全面研究。虽然在农场动物中,噬菌体疗法的疗效前景已在体外和体内得到广泛研究,特别是针对人畜共患病和与经济损失相关的疾病(如乳腺炎),但在宠物方面,相关研究仍然较少且相当新。